Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP177703.RABvGl4K39DJCXSfO4UBXFb1-z0cZb9ef-51xYC26Y-c8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP177703.RABvGl4K39DJCXSfO4UBXFb1-z0cZb9ef-51xYC26Y-c8130_assertion type Assertion NP177703.RABvGl4K39DJCXSfO4UBXFb1-z0cZb9ef-51xYC26Y-c8130_head.
- NP177703.RABvGl4K39DJCXSfO4UBXFb1-z0cZb9ef-51xYC26Y-c8130_assertion description "[Additionally, 698 CNPs showed significant differences with false discovery rate (FDR)<0.01 among the 10 populations and these loci overlap with known disease-associated or pharmacogenetic-related genes such as CFHR3 and CFHR1 (age related macular degeneration), GSTTI (metabolism of various carcinogenic compounds and cancers) and UGT2B17 (prostate cancer and graft-versus-host disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP177703.RABvGl4K39DJCXSfO4UBXFb1-z0cZb9ef-51xYC26Y-c8130_provenance.
- NP177703.RABvGl4K39DJCXSfO4UBXFb1-z0cZb9ef-51xYC26Y-c8130_assertion evidence source_evidence_literature NP177703.RABvGl4K39DJCXSfO4UBXFb1-z0cZb9ef-51xYC26Y-c8130_provenance.
- NP177703.RABvGl4K39DJCXSfO4UBXFb1-z0cZb9ef-51xYC26Y-c8130_assertion SIO_000772 21677662 NP177703.RABvGl4K39DJCXSfO4UBXFb1-z0cZb9ef-51xYC26Y-c8130_provenance.
- NP177703.RABvGl4K39DJCXSfO4UBXFb1-z0cZb9ef-51xYC26Y-c8130_assertion wasDerivedFrom befree-20140225 NP177703.RABvGl4K39DJCXSfO4UBXFb1-z0cZb9ef-51xYC26Y-c8130_provenance.
- NP177703.RABvGl4K39DJCXSfO4UBXFb1-z0cZb9ef-51xYC26Y-c8130_assertion wasGeneratedBy ECO_0000203 NP177703.RABvGl4K39DJCXSfO4UBXFb1-z0cZb9ef-51xYC26Y-c8130_provenance.